Program
Ningmitai capsule
Also written as “Ningmitai Capsule”.
Its studies are mostly in Prostatitis · Calculi · Ureteral Calculi, led by Xintian Pharmaceutical.
Furthest: phase 4, since May 23, 20235 company-led studies, 1 open or runningNext primary completion: Oct 31, 2028 (phase 4)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Xintian Pharmaceutical | 51 open or running | phase 4since May 23, 2023 | May 23, 2023 | Oct 31, 2028phase 4 · NCT07914686 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- May 23, 2023First study: phase 4 study in Chronic ProstatitisFirst studyNCT05890235 · 323 enrolled · China
- Sep 26, 2023Phase 4 study in ProstatitisNCT06064448 · 254 enrolled · China
- Oct 23, 2023Phase 4 study in Ureteral CalculiNCT06105827 · 251 enrolled
- Nov 19, 2023Phase 4 study in Chronic ProstatitisNCT06159114 · 242 enrolled · China
- Oct 27, 2026Phase 4 study in Calculus of Upper Urinary TractNCT07914686 · 100 planned
Ahead
- Oct 31, 2028Primary completion: phase 4 study in Calculus of Upper Urinary TractNCT07914686
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07914686Calculus of Upper Urinary Tract | 4 | Not yet recruiting | Oct 31, 2028 | 100 |
| NCT06159114Chronic Prostatitis · China | 4 | Completed | Jan 31, 2025 | 242 |
| NCT06105827Ureteral Calculi | 4 | Completed | Apr 25, 2019 | 251 |
| NCT06064448Prostatitis · China | 4 | Completed | Dec 22, 2022 | 254 |
| NCT05890235Chronic Prostatitis · China | 4 | Completed | Jul 10, 2022 | 323 |
How it is read
Names in the registry
- “Ningmitai capsule”, 3 entries
- “Ningmitai Capsule”, 2 entries
Conditions, from the studies’ own filings
- Prostatitis, 3 studies
- Calculi, 1 study
- Ureteral Calculi, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.